Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

Otulipenia: From Inflammatory Case Studies to Treatment

Lara C. Pullen, PhD  |  October 24, 2016

Otulipenia is a recently discovered autoinflammatory disease caused by germline mutations, which results in dysregulated ubiquitination in patients. In a small-scale study, researchers used exome sequencing and candidate gene screening to identify three different loss-of-function mutations in the OTULIN/FAM105B gene in patients…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:geneticgenetic mutationgermline mutationinflammationotulipeniaubiquitin pathway

Cigna Ends Preauthorization Requirement to Treat Opioid Addiction

Reuters Staff  |  October 22, 2016

(Reuters)—Health insurer Cigna Corp. has discontinued its policy of requiring doctors to seek authorization before treating opioid addicts, as part of a fight against an epidemic of opioid abuse, New York Attorney General Eric Schneiderman said on Friday. The policy change will apply nationally, says Schneiderman, who has been pushing for easier access to treatments…

Filed under:Legal Updates Tagged with:Cigna Corp.DrugsHealth InsuranceHealthcareOpioid abuseOpioids

Choose the Right EHR the 1st Time

Karen Appold  |  October 20, 2016

With so many electronic health record (EHR) systems on the market, it can be difficult to decide which one to choose. You may want to ask your peers for recommendations, visit practices that are using a system you’re contemplating and consider advice in trade journals. Jeffrey G. Lawson, MD, physician, Piedmont Arthritis Clinic, Greenville, S.C.,…

Filed under:EMRsPractice SupportProfessional Topics Tagged with:EHRElectronic health records

Liposomal Bupivacaine Helpful in Total Knee Arthroplasty

David Douglas  |  October 19, 2016

NEW YORK (Reuters Health)—Local infiltration of liposomal bupivacaine in patients undergoing total knee arthroplasty (TKA) curbed use of opioids and antiemetics and appeared to be both beneficial and cost effective in a recent study. As Dr. Bryan Sakamoto told Reuters Health by email, the results “suggest that liposomal bupivacaine is effective as part of a…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:kneeknee arthroplastyliposomal bupivacainetotal knee replacement

Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

Susan Bernstein  |  October 11, 2016

Established wisdom holds that patients with rheumatoid arthritis (RA) will fare better if their disease is diagnosed as early as possible, and treatments with disease-modifying drugs are started before inflammation can do more damage to joints and tissue. Usually, early diagnosis means spotting the clinical signs of disease, but new research tells us more about…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:identificationinterventionPathogenesispatient careResearchRheumatoid arthritisrheumatologyRisk Factors

State-of-the-Art Course on Interprofessional Management of Rheumatoid Arthritis

Maura Iversen  |  October 11, 2016

During an interactive, case-based course at the 2016 ACR/ARHP Annual Meeting, participants will develop strategies to help patients manage unique barriers to access to care and adherence…

Filed under:ConditionsEducation & TrainingPediatric ConditionsProfessional Topics Tagged with:ACR/ARHPACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)EducationelderlyPediatricRheumatiod arthritis

Rheumatology Drug Updates: Abaloparatide Promising for Osteoporosis, Plus Secukinumab for Ankylosing Spondylitis

Michele B. Kaufman, PharmD, BCGP  |  October 10, 2016

Abaloparatide for Osteoporosis Abaloparatide is completing Phase III clinical trials for the potential treatment of postmenopausal osteoporosis in women who are at an increased risk of fracture.1 Abaloparatide is a synthetic peptide that engages the parathyroid hormone receptor and has favorable bone building activity. Abaloparatide has completed Phase 3 development for use as a daily…

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:abaloparatideAnkylosing SpondylitisApprovalsclinical trialsdrugFDAOsteoporosisRheumatic DiseaserheumatologySafetysecukinumab

Rheumatologists on the Move, October 2016

Ann-Marie Lindstrom  |  October 10, 2016

Dr. Amanda King Elected President of Caribbean Association for Rheumatology The Caribbean Association for Rheumatology (CAR) elected Amanda King, MBBS(UWI), MRCP(UK), FRCP(Glas.), president during the 7th Annual CAR Scientific Meeting this summer. This year’s CAR meeting concentrated on education for general practitioners, because there are still some islands without a rheumatologist. She is the only rheumatologist…

Filed under:Career Development Tagged with:appointmentsAwardsCareerpromotionrheumatologist

Rheumatologist, Jazz Guitarist Dr. Alan Schenk Connects with Patients, Colleagues by Playing Music

Linda Childers  |  October 10, 2016

It’s not uncommon for a new patient to arrive at the medical offices of Alan Schenk, MD, in Laguna Woods, Calif., and immediately ask him about his musical career. In addition to being a board-certified rheumatologist for the past 32 years, Dr. Schenk is also an accomplished acoustic jazz guitarist and mandolin player. Music First “I…

Filed under:Profiles Tagged with:Dr. Alan Schenkhobbypatient carerheumatologist

Rheumatologist Dr. Richard Meehan Discusses Tour of Medical Duty in Gulf War, Iraq War

Carol Patton  |  October 10, 2016

Richard Meehan, MD, can still hear the distinctive sound of footsteps that would travel along a gravel path toward his wooden hut in the middle of the night in Iraq. “I’d hear somebody walk from the command post, either toward my hut or the operations officer who slept in the hut next to mine,” says…

Filed under:Profiles Tagged with:Dr. Richard MeehanGulf WarinjuryIraq Warpatient carephysicianrheumatologisttrauma

  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 162
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences